SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,236 | -51.3% | 2,620 | -1.9% | 0.00% | – |
| Q2 2023 | $12,794 | +426366.7% | 2,671 | +352.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 590 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 590 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 590 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 590 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -91.8% | 590 | -90.0% | 0.00% | – |
| Q4 2021 | $49,000 | +1125.0% | 5,890 | +898.3% | 0.00% | – |
| Q3 2021 | $4,000 | -95.7% | 590 | -84.8% | 0.00% | -100.0% |
| Q2 2021 | $93,000 | +675.0% | 3,890 | +559.3% | 0.00% | – |
| Q1 2021 | $12,000 | -80.6% | 590 | -76.8% | 0.00% | – |
| Q4 2020 | $62,000 | -22.5% | 2,540 | -10.6% | 0.00% | -100.0% |
| Q3 2020 | $80,000 | +1500.0% | 2,840 | +186.9% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 990 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -94.0% | 990 | -76.4% | 0.00% | -100.0% |
| Q3 2017 | $67,000 | +34.0% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |